Resource Logo

DOTS and drug resistance: a silver lining to a darkening cloud [editorial; comment]


Int J Tuberc Lung Dis. 1999 Jan;3(1):1-3. Unique Identifier : AIDSLINE

COMMENT EDITORIAL JOURNAL ARTICLE Antitubercular Agents/*ADMINISTRATION & DOSAGE Botswana/EPIDEMIOLOGY Comorbidity Drug Resistance, Microbial Human HIV Infections/EPIDEMIOLOGY Incidence Mycobacterium tuberculosis/DRUG EFFECTS *Patient Compliance Prevalence Program Development Tuberculosis, Multidrug-Resistant/DRUG THERAPY/*EPIDEMIOLOGY/ PREVENTION & CONTROL Tuberculosis, Pulmonary/DRUG THERAPY/*EPIDEMIOLOGY/PREVENTION & CONTROL World Health


Information in this article was accurate in July 30, 1999. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.